enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2025)

enVVeno Medical has reported Cash from Financing Activities for 7 years, with the latest figure at $782000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to $782000.0; the trailing twelve-month figure through Dec 2025 stood at $14.4 million (up 5.4% YoY), and the FY2025 full-year result was $1.0 million, down 92.5% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $782000.0, down from $13.6 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $38.4 million in Q1 2021, with the low at -$4000.0 in Q4 2021.
• Average Cash from Financing Activities over 3 years is $12.0 million, with a median of $7.2 million recorded in 2024.
• Peak annual rise in Cash from Financing Activities reached 6627.2% in 2021, while the deepest fall reached 100.06% in 2021.
• Tracing NVNO's Cash from Financing Activities over 3 years: stood at -$4000.0 in 2021, then jumped by 339875.0% to $13.6 million in 2024, then sank by 94.25% to $782000.0 in 2025.
• The last three Cash from Financing Activities figures came in at $782000.0 (Q4 2025), $13.6 million (Q3 2024), and $46000.0 (Q1 2024), per Business Quant data.

Peer Comparison